Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory

• Main Authors: Wenhao Luo, Gang Yang, Wentao Luo, Zhe Cao, Yueze Liu, Jiangdong Qiu, Guangyu Chen, Lei You, Fangyu Zhao, Lianfang Zheng, Taiping Zhang
• Format: Article
• Language: English
• Published: BMC 2020-03-01
• Series: Cancer Cell International
• Subjects: Vaccination; Pancreatic cancer; Metastasis; Immune therapy; Novel strategies
• Online Access: http://link.springer.com/article/10.1186/s12935-020-1147-9

Abstract Pancreatic cancer is an aggressive and malignant tumor with an exceedingly high mortality rate. The quality of life and survival rates of pancreatic cancer patients with metastasis are poor compared with those without metastasis. Thus far, no effective treatment strategy has been established for metastatic pancreatic cancer patients. Therefore, an appropriate therapeutic method based on the elimination of metastatic pancreatic cancer is critical to improve patient outcome. Tumor-targeted vaccines have been widely discussed in recent studies and enabled important breakthroughs in the treatment of pancreatic cancer by preventing the escape of tumor cells from immune surveillance and activating the immune system to eliminate cancer cells. T cells can be activated by the stimulation of tumor-targeted vaccines, but to mount an effective immune response, both immune checkpoint inhibitors and positive costimulatory molecules are required. In this review, we discuss potential tumor-targeted vaccines that can target pancreatic cancer, elaborate the probably appropriate combination of vaccines therapy and evaluate the underlying benefits as well as obstacles in the current therapy for metastatic pancreatic cancer.